Aug 3, 2021

Hahn-Schickard and Endress+Hauser establish "Endress+Hauser BioSense" joint venture

Food safety is one application area for the molecular analysis solutions that Endress+Hauser BioSense, a joint venture between Endress+Hauser and Hahn-Schickard, aims to develop in Freiburg, Germany.
Source: Endress+Hauser
Aug 3, 2021

Endress+Hauser BioSense GmbH develops methods for molecular analysis and greater safety in the food sector. Bacterial or viral contaminations in water and beverages, genetic changes in food, or the contamination of milk can thus be analyzed quickly.

Cooperation with the University of Freiburg

Hahn-Schickard has been working closely with the University of Freiburg for many years to develop rapid diagnostic methods that can detect even the smallest amounts of infectious pathogens on-site using mobile equipment. Last year, a rapid PCR test for SARS-CoV-2 was jointly launched. This technology is to be transferred from medical diagnostics to the application areas of industrial process and laboratory automation with the help of the new joint venture between Hahn-Schickard and Endress+Hauser.

Experienced management team

Endress+Hauser BioSense GmbH was founded in Freiburg, Germany, and will move next year to the Freiburg Innovation Center FRIZ, currently under construction on the campus of the Technical Faculty. Dr. Nicholas Krohn, Managing Director at Eurofins Genescan GmbH in Freiburg for many years and very familiar with the field of food analysis, has been recruited as Managing Director. The founding team is complemented by Dr. Stefan Burger and Dr. Martin Schulz, two long-standing and experienced Hahn-Schickard employees who have completed their doctorates in the field of molecular diagnostics at the Technical Faculty of the Albert Ludwig University in Freiburg.

Contact: Katrin Grötzinger, Hahn-Schickard
Katrin.Groetzinger@Hahn-Schickard.de

Member profile

Recommended articles

Dec 3, 2024

COMPAMED 2024 once again consolidated its position as the leading international trade fair for medical technology supplies. The IVAM joint …

Jan 24, 2024

MD&M West in Anaheim stands out as one of the premier global platforms dedicated to showcasing advancements in medical technology …

Dec 20, 2023

COMPAMED, held in Düsseldorf in November parallel to MEDICA, has established itself as an outstanding platform for key technologies in …

Recommended events

Jun 5, 2025, 2:30 p.m. - 5:00 p.m.
Pioneering Cancer Detection: From Early Diagnosis to Precision Medicine
Sep 10 - 12, 2025
Special Exhibiting Area ‘’Manufacturing Processes and Components for Medical Technology’’
Nov 17 - 20, 2025
Product Market “High-tech for Medical Devices”: A hub for high-tech solutions and medical innovations. Team up with IVAM to pave your way to trade fair success!